Nursing: Medications Exam Questions
with correct Answers 2025/2026 A+
Graded 100% Verified
Bumetanide - ANS-Brand name: Bumex
Therapeutic Effects: diuresis and subsequent mobilization of excess fluid (edema, pleural
effusion)
Therapeutic Classification: diuretics
Pharmacologic Classification: loop diuretics
Bumetanide: Nursing Implications - ANS-- monitor daily weight, intake and output ratios,
amount and location of edema, lung sounds, skin turgor, and mucous membranes
- monitor BP and pulse before and during administration
- assess patients for tinnitus and hearing loss
- assess for allergy to sulfonamides
- assess patient for skin rash frequently during therapy
- geri: assess falls risk and implement fall prevent strategies
Bumetanide: Side Effects - ANS-CNS: dizziness, encephalopathy, headache
EENT: hearing loss, tinnitus
CV: hypotension
GI: diarrhea, dry mouth, nausea, vomiting
GU: increased BUN, excessive urination
Derm: Stevens-Johnson syndrome, toxic epidermal necrolysis, photosensitivity, pruritis, rash
Endo: hyperglycemia, hyperuricemia
F and E: dehydration, hypocalcemia, hypochloremia, hypokalemia, hypomagnesemia,
hyponatremia, nypovolemia, metabolic alkalosis
MS: arthralgia, muscle cramps, myalgia
Bumetanide: Patient Teaching - ANS-- caution patient to change positions slowly to minimize
orthostatic hypotension
- caution patient that drinking alcohol, exercising during hot weather, or standing for long periods
may enhance orthostatic hypotension
- instruct patient to consult health care professional regarding a diet high in potassium
- advise patient to contact health care professional of gain more than 3 lbs in one day.
- caution patient to use sunscreen and protective clothing to prevent photosensitivity reactions.
- advise patient to contact health care professional immediately if rash, muscle weakness,
cramps, nausea, dizziness, numbness, or tingling of extremities occurs.
,- advise patients with diabetes to monitor blood glucose closely; may cause increased levels.
- Geri: caution older patients or their caregivers about increased risk for falls; suggest strategies
for fall prevention.
Heparin - ANS-Brand Name: Hep-Lock, Hep-Lock U/P
Therapeutic Effect:
- prevention of thrombus formation
- prevention of extension of existing thrombi (full dose)
Antidote: Protamine sulfate
Therapeutic Classification: anticoagulants
Pharmacologic Classification: antithrombotics
Heparin: Side Effects - ANS-GI: drug-induced hepatitis
Derm: alopecia (long-term use), rashes, urticaria
Hemat: bleeding , heparin-induced thrombocytopenia (HIT) (with or without thrombosis), anemia
Local: pain at injection site
MS: osteoporosis (long-term use)
Misc: fever, hypersensitivity
Heparin: Nursing Implications - ANS-- assess for signs of bleeding and hemorrhage: bleeding
gums; nosebleed; unusual bruising; black, tarry stools; hematuria; fall in hematocrit or BP;
guaiac-positive stools
- assess patient for evidence of additional or increased thrombosis; symptoms will depend on
area of involvement
- monitor patient for hypersensitivity reactions
- SC: Observe injection sites for hematomas, ecchymosis, or inflammation
Heparin: Patient Teaching - ANS-- advise patient to report any symptoms of unusual bleeding
or bruising to health care professional immediately
- instruct patient not to take medications containing aspirin or NSAIDs while on heparin therapy
- caution patient to avoid IM injections and activities leading to injury and to use a soft
toothbrush and electric razor during heparin therapy
- advise patient to inform health care professional of medication regimen prior to treatment or
surgery
- patients on anticoagulant therapy should carry an identification card with this information at all
times
Nystatin - ANS-Brand Names: Mycostatin, Nilstat
Therapeutic Effects:
fungistatic or fungicidal action
Spectrum: active against most pathogenic Candida species, including C. albicans
Therapeutic Classification: antifungals (topical/local)
Nystatin: Side Effects - ANS-GI: diarrhea, nausea, stomach pain (large doses), vomiting
, Derm: contact dermatitis, Stevens-Johnson syndrome
Nystatin: Nursing Implications - ANS-- inspect oral mucous membranes before and frequently
throughout therapy
- increased irritation of mucous membranes may indicate need to discontinue medication
Nystatin: Patient Teaching - ANS-- therapy should be continued for at least 2 days after
symptoms subside
- pedi: instruct parents or caregivers of infants and children on correct dose and administration;
remind them to use only the measuring devise dispensed with the product
- advise patient to report increased irritation of mucous membranes or lack of therapeutic
response to health care professional
Lispro Insulin RDNA Origin - ANS-Brand Name: HumaLOG
Therapeutic Effects: control of hyperglycemia in diabetic patients
Therapeutic Classification: antidiabetics, hormones
Pharmacologic Classification: pancreatics
Lispro Insulin RDNA Origin: Side Effects - ANS-Endo: hypoglycemia
Local: lipodystrophy, pruritus, erythema, swelling
Misc: allergic reactions including anaphylaxis
Lispro Insulin RDNA Origin: Nursing Implications - ANS-- assess for symptoms of
hypoglycemia:
anxiety; restlessness; tingling in hands, feet, lips, or tongue; chills; cold sweats; confusion; cool,
pale skin; difficulty in concentration; drowsiness; nightmares or trouble sleeping; excessive
hunger; headache; irritability; nausea; nervousness; tachycardia; tremor; weakness; unsteady
gait
- assess for symptoms of hyperglycemia:
confusion, drowsiness; flushed, dry skin; fruit-like breath odor; rapid, deep breathing, polyuria;
loss of appetite; unusual thirst
- monitor body weight periodically; changes in weight may necessitate changes in insulin dose
Lispro Insulin RDNA Origin: Patient Teaching - ANS-- instruct patient on proper technique for
administration:
type of insulin, equipment (syringe, cartridge pens, external pumps, alcohol swabs), storage,
and place to discard syringes
- discuss the importance of not changing brands of insulin or syringes, selection and rotation of
injection sites, and compliance with therapeutic regimen
- demonstrate technique for mixing insulins by drawing up insulin lispro first and rolling
intermediate-acting insulin vial between palms to mix, rather than shaking (may cause
inaccurate dose)
- explain to patient that this medication controls hyperglycemia but does not cure diabetes;
therapy is long term.
with correct Answers 2025/2026 A+
Graded 100% Verified
Bumetanide - ANS-Brand name: Bumex
Therapeutic Effects: diuresis and subsequent mobilization of excess fluid (edema, pleural
effusion)
Therapeutic Classification: diuretics
Pharmacologic Classification: loop diuretics
Bumetanide: Nursing Implications - ANS-- monitor daily weight, intake and output ratios,
amount and location of edema, lung sounds, skin turgor, and mucous membranes
- monitor BP and pulse before and during administration
- assess patients for tinnitus and hearing loss
- assess for allergy to sulfonamides
- assess patient for skin rash frequently during therapy
- geri: assess falls risk and implement fall prevent strategies
Bumetanide: Side Effects - ANS-CNS: dizziness, encephalopathy, headache
EENT: hearing loss, tinnitus
CV: hypotension
GI: diarrhea, dry mouth, nausea, vomiting
GU: increased BUN, excessive urination
Derm: Stevens-Johnson syndrome, toxic epidermal necrolysis, photosensitivity, pruritis, rash
Endo: hyperglycemia, hyperuricemia
F and E: dehydration, hypocalcemia, hypochloremia, hypokalemia, hypomagnesemia,
hyponatremia, nypovolemia, metabolic alkalosis
MS: arthralgia, muscle cramps, myalgia
Bumetanide: Patient Teaching - ANS-- caution patient to change positions slowly to minimize
orthostatic hypotension
- caution patient that drinking alcohol, exercising during hot weather, or standing for long periods
may enhance orthostatic hypotension
- instruct patient to consult health care professional regarding a diet high in potassium
- advise patient to contact health care professional of gain more than 3 lbs in one day.
- caution patient to use sunscreen and protective clothing to prevent photosensitivity reactions.
- advise patient to contact health care professional immediately if rash, muscle weakness,
cramps, nausea, dizziness, numbness, or tingling of extremities occurs.
,- advise patients with diabetes to monitor blood glucose closely; may cause increased levels.
- Geri: caution older patients or their caregivers about increased risk for falls; suggest strategies
for fall prevention.
Heparin - ANS-Brand Name: Hep-Lock, Hep-Lock U/P
Therapeutic Effect:
- prevention of thrombus formation
- prevention of extension of existing thrombi (full dose)
Antidote: Protamine sulfate
Therapeutic Classification: anticoagulants
Pharmacologic Classification: antithrombotics
Heparin: Side Effects - ANS-GI: drug-induced hepatitis
Derm: alopecia (long-term use), rashes, urticaria
Hemat: bleeding , heparin-induced thrombocytopenia (HIT) (with or without thrombosis), anemia
Local: pain at injection site
MS: osteoporosis (long-term use)
Misc: fever, hypersensitivity
Heparin: Nursing Implications - ANS-- assess for signs of bleeding and hemorrhage: bleeding
gums; nosebleed; unusual bruising; black, tarry stools; hematuria; fall in hematocrit or BP;
guaiac-positive stools
- assess patient for evidence of additional or increased thrombosis; symptoms will depend on
area of involvement
- monitor patient for hypersensitivity reactions
- SC: Observe injection sites for hematomas, ecchymosis, or inflammation
Heparin: Patient Teaching - ANS-- advise patient to report any symptoms of unusual bleeding
or bruising to health care professional immediately
- instruct patient not to take medications containing aspirin or NSAIDs while on heparin therapy
- caution patient to avoid IM injections and activities leading to injury and to use a soft
toothbrush and electric razor during heparin therapy
- advise patient to inform health care professional of medication regimen prior to treatment or
surgery
- patients on anticoagulant therapy should carry an identification card with this information at all
times
Nystatin - ANS-Brand Names: Mycostatin, Nilstat
Therapeutic Effects:
fungistatic or fungicidal action
Spectrum: active against most pathogenic Candida species, including C. albicans
Therapeutic Classification: antifungals (topical/local)
Nystatin: Side Effects - ANS-GI: diarrhea, nausea, stomach pain (large doses), vomiting
, Derm: contact dermatitis, Stevens-Johnson syndrome
Nystatin: Nursing Implications - ANS-- inspect oral mucous membranes before and frequently
throughout therapy
- increased irritation of mucous membranes may indicate need to discontinue medication
Nystatin: Patient Teaching - ANS-- therapy should be continued for at least 2 days after
symptoms subside
- pedi: instruct parents or caregivers of infants and children on correct dose and administration;
remind them to use only the measuring devise dispensed with the product
- advise patient to report increased irritation of mucous membranes or lack of therapeutic
response to health care professional
Lispro Insulin RDNA Origin - ANS-Brand Name: HumaLOG
Therapeutic Effects: control of hyperglycemia in diabetic patients
Therapeutic Classification: antidiabetics, hormones
Pharmacologic Classification: pancreatics
Lispro Insulin RDNA Origin: Side Effects - ANS-Endo: hypoglycemia
Local: lipodystrophy, pruritus, erythema, swelling
Misc: allergic reactions including anaphylaxis
Lispro Insulin RDNA Origin: Nursing Implications - ANS-- assess for symptoms of
hypoglycemia:
anxiety; restlessness; tingling in hands, feet, lips, or tongue; chills; cold sweats; confusion; cool,
pale skin; difficulty in concentration; drowsiness; nightmares or trouble sleeping; excessive
hunger; headache; irritability; nausea; nervousness; tachycardia; tremor; weakness; unsteady
gait
- assess for symptoms of hyperglycemia:
confusion, drowsiness; flushed, dry skin; fruit-like breath odor; rapid, deep breathing, polyuria;
loss of appetite; unusual thirst
- monitor body weight periodically; changes in weight may necessitate changes in insulin dose
Lispro Insulin RDNA Origin: Patient Teaching - ANS-- instruct patient on proper technique for
administration:
type of insulin, equipment (syringe, cartridge pens, external pumps, alcohol swabs), storage,
and place to discard syringes
- discuss the importance of not changing brands of insulin or syringes, selection and rotation of
injection sites, and compliance with therapeutic regimen
- demonstrate technique for mixing insulins by drawing up insulin lispro first and rolling
intermediate-acting insulin vial between palms to mix, rather than shaking (may cause
inaccurate dose)
- explain to patient that this medication controls hyperglycemia but does not cure diabetes;
therapy is long term.
